Radiopharm Theranostics (RADX) Invested Capital (2024 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Radiopharm Theranostics (RADX) has disclosed Invested Capital for 2 consecutive years, with $75.0 million as the latest value for Q2 2025.

• On a quarterly basis, Invested Capital rose 23.35% to $75.0 million in Q2 2025 year-over-year; TTM through Jun 2025 was $75.0 million, a 23.35% increase, with the full-year FY2025 number at $75.0 million, up 23.35% from a year prior.
• Invested Capital was $75.0 million for Q2 2025 at Radiopharm Theranostics, up from $60.8 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $75.0 million in Q2 2025 to a low of $60.8 million in Q2 2024.

Peer Comparison